Principal investigator Peter E. Legnani, MD, clinical instructor in the Division of Gastroenterology, Samuel Bronfman Department of Medicine, presented the findings in New Orleans at Digestive Disease Week, the world's largest and most prestigious meeting on gastroenterology.
Researchers found that among patients with confirmed Crohn's disease, clinical decisions based on capsule endoscopy findings improved outcomes in 95% of patients. The investigators also demonstrated that capsule endoscopy was 100 percent effective in excluding a diagnosis of Crohn's disease.
"Capsule endoscopy is a highly effective tool in the diagnosis and therapeutic decision making of patients with IBD-related illnesses," said Dr. Legnani. "The results derived from capsule endoscopy procedures positively affect patient management, helping physicians guide their treatment decisions with the ultimate goal of improving outcomes in this patient population."
The study reviewed the diagnostic findings from the capsule endoscopies of 65 patients with Inflammatory Bowel Disease (IBD)-related indications and examined the effect of those findings on diagnostic and therapeutic outcomes. Patients admitted to the study had evidence of IBD diagnosed through prior endoscopic procedures. The patients were segmented into suspected or confirmed Crohn's disease and further categorized by the results of previous tests. In patients with an abnormal small bowel series or abdominal pain, 30 of 32 were found not to have Crohn's. Based on a 19 month follow-up confirming the absence of Crohn's disease, capsule endoscopy demonstrated a neg
'"/>
Contact: Mount Sinai Press Office
NewsMedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-May-2004